Bse LargeMidCap

In compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Star Health and Allied Insurance Company has informed that the Company will be meeting Investor/Analyst at the Motilal Oswal 22nd Annual Global Investor Conference, 2026 on Thursday, 17th August, 2026 at 10:00 AM onwards in Mumbai. The link for accessing the presentation of the meeting is given below: https://d28c6jni2fmamz.cloudfront.net/8_ECPQ_1_FY_27_8dec5fbe94.pdf. The above disclosure will also be made available on the Company’s website at www.starhealth.in.

The above information is a part of company’s filings submitted to BSE.  

With reference to earlier intimations regarding the filing of a ‘short-form’ and subsequently, a ‘long-form’ declaration with the Committee on Foreign Investment in the United States [‘CFIUS’] in connection with the proposed acquisition of AluChem Companies, Inc, Hindalco Industries has informed that due to partial shutdown of the U.S. federal government, the statutory timelines under the CFIUS review framework were tolled, thereby impacting the ongoing CFIUS review process. The matter, however, is progressing and is anticipated to reach finality by September 2, 2026. This timeline remains subject to receipt of final clearance. The company will provide further updates as and when material developments occur or upon completion of the review process. All other details, as per its referred intimations, remain unchanged. This is also made available on the website of the Company www.hindalco.com.